HK1139052A1 - Composition for transdermal administration - Google Patents

Composition for transdermal administration

Info

Publication number
HK1139052A1
HK1139052A1 HK10104926.9A HK10104926A HK1139052A1 HK 1139052 A1 HK1139052 A1 HK 1139052A1 HK 10104926 A HK10104926 A HK 10104926A HK 1139052 A1 HK1139052 A1 HK 1139052A1
Authority
HK
Hong Kong
Prior art keywords
composition
transdermal administration
transdermal
administration
Prior art date
Application number
HK10104926.9A
Other languages
English (en)
Inventor
Fumio Yoneda
Hironori Ohde
Mayumi Watanabe
Mikiyo Sugimoto
Takahiro Kamada
Mizue Hukumoto
Azusa Takase
Naoya Hoshino
Original Assignee
Fujimoto Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Co Ltd filed Critical Fujimoto Co Ltd
Publication of HK1139052A1 publication Critical patent/HK1139052A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
HK10104926.9A 2007-06-21 2010-05-19 Composition for transdermal administration HK1139052A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007163692 2007-06-21
PCT/JP2008/061300 WO2008156160A1 (ja) 2007-06-21 2008-06-20 経皮または経粘膜投与用組成物

Publications (1)

Publication Number Publication Date
HK1139052A1 true HK1139052A1 (en) 2010-09-10

Family

ID=40156318

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104926.9A HK1139052A1 (en) 2007-06-21 2010-05-19 Composition for transdermal administration

Country Status (14)

Country Link
US (2) US20100137429A1 (ja)
EP (1) EP2158908B1 (ja)
JP (1) JP5754885B2 (ja)
KR (1) KR101500022B1 (ja)
CN (1) CN101677988A (ja)
AU (1) AU2008264476B2 (ja)
CA (1) CA2690945C (ja)
DK (1) DK2158908T3 (ja)
ES (1) ES2409554T3 (ja)
HK (1) HK1139052A1 (ja)
IL (1) IL202221A (ja)
PT (1) PT2158908E (ja)
SI (1) SI2158908T1 (ja)
WO (1) WO2008156160A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820206B2 (ja) * 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
KR102198540B1 (ko) * 2015-11-25 2021-01-06 삼성전기주식회사 적층 세라믹 커패시터 및 그 실장 기판
CN110430879B (zh) * 2017-03-24 2023-04-21 细胞内治疗公司 新组合物和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US5879690A (en) * 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
JP4569980B2 (ja) * 1997-08-07 2010-10-27 株式会社フジモト・コーポレーション 新規なエチルアミン誘導体
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
DE60045153D1 (de) * 1999-04-13 2010-12-09 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
DE19934592C2 (de) 1999-07-23 2003-10-23 Benckiser Nv Vorrichtung zur Aufnahme und dosierten Abgabe einer aktiven Zusammensetzung in eine Waschmaschine, einen Wäschetrockner oder eine Geschirrspülmaschine
JP4659336B2 (ja) * 2000-10-26 2011-03-30 アルザ・コーポレーシヨン 被覆された微細突出物を有する経皮的薬剤配達装置
WO2002094378A2 (en) * 2001-05-22 2002-11-28 Active Pass Pharmaceuticals, Inc. Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease
JP4953040B2 (ja) 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
JP5030194B2 (ja) * 2004-11-25 2012-09-19 国立大学法人九州大学 薬物依存症治療剤
WO2006082888A1 (ja) 2005-02-03 2006-08-10 Kyorin Pharmaceutical Co., Ltd. 経皮吸収型製剤

Also Published As

Publication number Publication date
KR101500022B1 (ko) 2015-03-06
DK2158908T3 (da) 2013-07-29
KR20100023884A (ko) 2010-03-04
AU2008264476A1 (en) 2008-12-24
CN101677988A (zh) 2010-03-24
CA2690945C (en) 2015-07-21
US20130005800A1 (en) 2013-01-03
AU2008264476B2 (en) 2013-03-28
ES2409554T3 (es) 2013-06-27
SI2158908T1 (sl) 2013-07-31
IL202221A0 (en) 2010-06-16
JP5754885B2 (ja) 2015-07-29
US20100137429A1 (en) 2010-06-03
EP2158908A1 (en) 2010-03-03
EP2158908A4 (en) 2011-03-30
IL202221A (en) 2017-04-30
EP2158908B1 (en) 2013-04-24
CA2690945A1 (en) 2008-12-24
JPWO2008156160A1 (ja) 2010-08-26
PT2158908E (pt) 2013-05-07
WO2008156160A1 (ja) 2008-12-24

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
IL228817A0 (en) Pharmaceutical compounds
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
IL200125A0 (en) Pharmaceutical composition
EP2236149A4 (en) MEDICAL COMPOSITION
EP2116242A4 (en) NEW PHARMACEUTICAL COMPOSITION
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
EP2226071A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
IL208387A0 (en) Pharmaceutical composition
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
ZA201006224B (en) Pharmaceutical composition
HK1139052A1 (en) Composition for transdermal administration
GB2464200B (en) Pharmaceutical composition
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
IL205975A0 (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
IL205931A0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition
GB0717036D0 (en) Pharmaceutical composition
GB0817974D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210619